Zeocin resistance as a dominant selective marker for transformation and targeted gene deletions in Candida glabrata

Mycoses

Volumn 49, Issue 6, 2006, Pages 445-451

  Alderton, Alex J ^a   Burr, Ian ^b   Mühlschlegel, Fritz A ^a   Tuite, Mick F ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Candida glabrata; Gene disruption; Zeocin

Indexed keywords

ANTIBIOTIC AGENT; ANTIBIOTIC G 418; BLE PROTEIN; FUNGAL PROTEIN; PHLEOMYCIN; UNCLASSIFIED DRUG; ZEOCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA GLABRATA; CONTROLLED STUDY; FUNGUS; GENE DELETION; GENE DISRUPTION; GENE TARGETING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STREPTOALLOTEICHUS HINDUSTANUS;

BLEOMYCIN; CANDIDA GLABRATA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; GENE DELETION; HUMANS; TRANSFORMATION, GENETIC;

CANDIDA GLABRATA; SACCHAROMYCES CEREVISIAE; STREPTOALLOTEICHUS HINDUSTANUS;

EID: 33749445600     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01271.x     Document Type: Article

References (33)

1. Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005; 56(Suppl. S1): i5-i11.
2. Samra Z, Bishara J, Ashkenazi S et al. Changing distribution of Candida species isolated from sterile and nonsterile sites in Israel. Eur J Clin Microbiol Infect Dis 2002; 21: 542-5.
3. Colombo AL, Perfect J, DiNubile M et al. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomised double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur J Clin Microbiol Infect Dis 2003; 22: 470-4.
4. Kaur R, Domergue R, Zupancic ML, Cormack BP. A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol 2005; 8: 378-84.
5. Pfaller MA, Diekema DJ, Jones RN et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254-9.
6. Diekema DJ, Messer SA, Brueggemann AB et al. Epidemiology of candidemia: 3-year results from emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002; 40: 1298-302.
7. Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999; 12: 80-96.
8. Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D. Antifungal drug resistance in pathogenic fungi. Med Mycol 1998; 36(Suppl. 1): 119-28.
9. Hsueh PR, Lau YJ, Chuang YC et al. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother 2005; 49: 512-7.
10. Nguyen MH, Peacock JE Jr, Morris AJ et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617-23.
11. Cormack BP, Falkow S. Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata. Genetics 1999; 151: 979-87.
12. Haynes K. Virulence in Candida species. Trends Microbiol 2001; 9: 591-6.
13. Kitada K, Yamaguchi E, Arisawa M. Cloning of the Candida glabrata TRP1 and HIS3 genes, and construction of their disruptant strains by sequential integrative transformation. Gene 1995; 165: 203-6.
14. Kitada K, Yamaguchi E, Arisawa M. Isolation of a Candida glabrata centromere and its use in construction of plasmid vectors. Gene 1996; 175: 105-8.
15. El Barkani A, Haynes K, Mosch H, Frosch M, Mühlschlegel FA. Candida glabrata shuttle vectors suitable for translational fusions to lacZ and use of beta-galactosidase as a reporter of gene expression. Gene 2000; 246: 151-5.
16. Koszul R, Malpertuy A, Frangeul L et al. The complete mitochondrial genome sequence of the pathogenic yeast Candida glabrata. FEBS Lett 2003; 534: 39-48.
17. Dujon B. (and 66 others) Genome evolution in yeasts. Nature 2004; 430: 35-44.
18. Santos MA, Keith G, Tuite MF. Non-standard translational events in Candida albicans mediated by an unusual seryl-tRNA with a 5′-CAG-3′ (leucine) anticodon. EMBO J 1993; 18: 607-16.
19. Weig M, Haynes K, Rogers TR, Kurzai O, Frosch M, Mühlschlegel FA. A GAS-like gene family in the pathogenic fungus Candida glabrata. Microbiology 2001; 147: 2007-19.
20. Willins DA, Shimer GH Jr, Cottarel G. A system for deletion and complementation of Candida glabrata genes amenable to high-throughput application. Gene 2002; 292: 141-9.
21. Edlind TD, Henry KW, Vermitsky J, Edlind MP, Raj S, Katiyar SK. Promoter-dependent disruption of genes: simple, rapid and specific PCR-based method with application to three different yeast. Curr Genet 2005; 48: 117-25.
22. Lay J, Henry LK, Clifford J, Koltin Y, Bulawa CE, Becker JM. Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun 1998; 66: 5301-6.
23. Bain JM, Stubberfield C, Gow NAR. Ura-status-dependent adhesion of Candida albicans mutants. FEMS Microbiol Lett 2001; 204: 323-8.
24. Sundstrom P, Cutler JE, Staab JF. Reevaluation of the role of HWP1 in systemic candidiasis by use of Candida albicans strains with selectable marker URA3 targeted to the ENO1 locus. Infect Immun 2002; 70: 3281-3.
25. Johansson B, Hahn-Hagerdal B. Overproduction of pentose phosphate pathway enzymes using a new CRE-loxP expression vector for repeated genomic integration in Saccharomyces cerevisiae. Yeast 2002; 19: 225-31.
26. Castano I, Kaur R, Pan S et al. Tn7-based genome-wide random insertional mutagenesis of Candida glabrata. Genome Res 2003; 13: 905-15.
27. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Struhl K. Current Protocols in Molecular Biology. New York, USA: Wiley, 1988.
28. Drocourt D, Calmels TPG, Reynes JP, Baron M, Tiraby G. Cassettes of the Streptoalloteichus hindustanus ble gene for transformation of lower and higher eukaryotes to phleomycin resistance. Nucleic Acids Res 1990; 18: 4009.
29. Sikorski RS, Hieter P. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 1989; 122: 19-27.
30. Güldener U, Heck S, Fielder T, Beinhauer J, Hegemann JH. A new efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids Res 1996; 24: 2519-24.
31. Zhou P, Szczypka MS, Young R, Thiele DJ. A system for gene cloning and manipulation in the yeast Candida glabrata. Gene 1994; 142: 135-40.
32. Hanic-Joyce PJ, Joyce PB. A high-copy-number ADE2-bearing plasmid for transformation of Candida glabrata. Gene 1998; 211: 395-400.
33. Van den Berg MA, Steensma HY. Expression cassettes for formaldehyde and fluoroacetate resistance, two dominant markers in Saccharomyces cerevisiae. Yeast 1997; 13: 551-9.